Capsule
RHINOBOL CAP
Summary
RHINOBOL CAP — Capsule containing brompheniramine maleate, phenylephrine hydrochloride. Hong Kong Registration No. HK-13707. Certificate Holder: ADVANCE PHARMACEUTICAL COMPANY LIMITED. Date of Registration: 19 Jul, 1980.
Product NameRHINOBOL CAP
Registration No.HK-13707
Certificate HolderADVANCE PHARMACEUTICAL COMPANY LIMITED
Holder AddressFLAT/RM A, 2/F - 3/F, 12 DAI FU STREET, TAI PO IND. ESTATE, TAI PO, NEW TERRITORIES
Ingredientsbrompheniramine maleate, phenylephrine hydrochloride
Dosage FormCapsule
Legal ClassificationPart 2 Poison
Sale RequirementOver-The-Counter Medicines
Date of Registration19 Jul, 1980
ATC codesC01CA06, C05AX06, R01AA04, R01AB01, R01BA03, R06AB01, S01FB01, S01GA05
ATC Classification
ATC level 1
C Cardiovascular System / R Respiratory System / S Sensory Organs
All ATC groupsC01, C05, R01, R06, S01
This product contains more than one active ingredient. The ATC groups above describe the ingredients, not a single category for the product as a whole.
本頁為藥物資料查詢工具，並非藥物廣告、推廣或醫療建議。所有資料取自香港特別行政區衞生署藥物辦公室之公開資料，僅供參考；一切以藥物辦公室官方公布為準。 本頁不提供任何療效、適應症或治療用途之陳述。用藥前請諮詢醫生或註冊藥劑師。 本網站遵守香港法例第 231 章《不良廣告（醫藥）條例》之規管。